Bulletin

Investor Alert

New York Markets Close in:

Moderna Inc.

NAS: MRNA

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Moderna Inc.

Market open

--Real time quotes

Jan 28, 2022, 12:35 p.m.

MRNA

/zigman2/quotes/205619834/composite

157.31

Change

+8.69 +5.85%

Volume

Volume 3.91m

Real time quotes

/zigman2/quotes/205619834/composite

Previous close

$ 148.62

$ 157.31

Change

+8.69 +5.85%

Day low

Day high

$146.76

$159.87

52 week low

52 week high

$117.34

$497.49

Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Moderna Inc.

View Ratios

Fiscal year is January-December. All values USD millions.	2016	2017	2018	2019	2020	5-year trend
Sales/Revenue	108.4M	205.83M	135.07M	60.21M	803.4M
Sales Growth	-	89.88%	-34.38%	-55.42%	1,234.34%
Cost of Goods Sold (COGS) incl. D&A	15.11M	20.54M	24.86M	31.02M	39.18M
COGS excluding D&A	-	-	-	-	7.93M
Depreciation & Amortization Expense	15.11M	20.54M	24.86M	31.02M	31.25M
Depreciation	15.11M	20.54M	24.86M	31.02M	31.25M
Amortization of Intangibles	-	-	-	-	-
COGS Growth	-	35.88%	21.06%	24.77%	26.31%
Gross Income	93.28M	185.29M	110.21M	29.19M	764.21M
Gross Income Growth	-	98.63%	-40.52%	-73.52%	2,518.24%
Gross Profit Margin	-	-	-	-	95.12%	NA

	2016	2017	2018	2019	2020	5-year trend
SG&A Expense	317.05M	454.64M	579.07M	574.91M	1.53B
Research & Development	274.72M	410.46M	509.68M	465.29M	1.34B
Other SG&A	42.34M	44.19M	69.39M	109.62M	188.27M
SGA Growth	-	43.40%	27.37%	-0.72%	165.67%
Other Operating Expense	-	-	-	-	-
Unusual Expense	-	-	-	-	1.6M
EBIT after Unusual Expense	-	-	-	-	(764.74M)
Non Operating Income/Expense	(2.71M)	(1.74M)	4.93M	(914,000)	5.4M
Non-Operating Interest Income	11.31M	15.24M	27.02M	38.53M	24.72M
Equity in Affiliates (Pretax)	-	-	-	-	-
Interest Expense	-	132,000	3.1M	6.61M	9.89M
Interest Expense Growth	-	-	2,245.45%	113.57%	49.52%
Gross Interest Expense	-	132,000	3.1M	6.61M	9.89M
Interest Capitalized	-	-	-	-	-
Pretax Income	(215.17M)	(256M)	(440.01M)	(514.72M)	(744.51M)
Pretax Income Growth	-	-18.97%	-71.88%	-16.98%	-44.65%
Pretax Margin	-	-	-	-	-92.67%	NA
Income Tax	1.04M	(80,000)	(55.27M)	(695,000)	2.55M
Income Tax - Current Domestic	755,000	(80,000)	326,000	505,000	32,000
Income Tax - Current Foreign	-	-	-	-	2.52M
Income Tax - Deferred Domestic	288,000	-	-	(1.2M)	-
Income Tax - Deferred Foreign	-	-	-	-	-
Income Tax Credits	-	-	55.6M	-	-
Equity in Affiliates	-	-	-	-	-
Other After Tax Income (Expense)	-	-	(4.13M)	-	-
Consolidated Net Income	(216.21M)	(255.92M)	(388.86M)	(514.02M)	(747.06M)
Minority Interest Expense	-	-	-	-	-
Net Income	(216.21M)	(255.92M)	(388.86M)	(514.02M)	(747.06M)
Net Income Growth	-	-18.36%	-51.95%	-32.19%	-45.34%
Net Margin Growth	-	-	-	-	-92.99%	NA
Extraordinaries & Discontinued Operations	-	-	-	-	-
Extra Items & Gain/Loss Sale Of Assets	-	-	-	-	-
Cumulative Effect - Accounting Chg	-	-	-	-	-
Discontinued Operations	-	-	-	-	-
Net Income After Extraordinaries	(216.21M)	(255.92M)	(388.86M)	(514.02M)	(747.06M)
Preferred Dividends	14.1M	13.93M	13M	-	-
Net Income Available to Common	(230.31M)	(269.84M)	(401.86M)	(514.02M)	(747.06M)
EPS (Basic)	(0.69)	(1.92)	(4.95)	(1.55)	(1.96)
EPS (Basic) Growth	-	-177.12%	-158.38%	68.63%	-26.08%
Basic Shares Outstanding	332.89M	140.6M	81.11M	330.8M	381.33M
EPS (Diluted)	(0.69)	(1.92)	(4.95)	(1.55)	(1.96)
EPS (Diluted) Growth	-	-177.12%	-158.38%	68.63%	-26.08%
Diluted Shares Outstanding	332.89M	140.6M	81.11M	330.8M	381.33M
EBITDA	(208.66M)	(248.82M)	(444M)	(514.7M)	(731.89M)
EBITDA Growth	-	-19.25%	-78.44%	-15.92%	-42.20%
EBITDA Margin	-	-	-	-	-91.10%	NA

Trending Tickers

/zigman2/quotes/200467500/composite NVDA+6.20%
/zigman2/quotes/201948298/composite BABA-5.69%
/zigman2/quotes/202092269/composite ENSC+36.10%
/zigman2/quotes/200164174/composite SNOA+74.50%
/zigman2/quotes/207683784/composite TIGR-10.38%

MarketWatch.com

Follow MarketWatch
RSS
Podcasts

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

Moderna Inc.

Annual Financials for Moderna Inc.

Latest News

dow

nasdaq

s&p 500

Kiosk